Immunovant, Inc.
Industry: Life Sciences ・ $IMVT on Nasdaq
Insider Sale
+$123,031
-0.52%
Shares
Shares Volume: 5,105 Shares
Average Share Price: $24.1
INSIDER
Salzmann Peter
Chief Executive Officer (Director)
reported on Jan 10 2025
traded on Jan 8 2025
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 972,992 |
| PURCHASES/SALES 1Y | 0 / 11 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $357,474.94 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 1 |
| PURCHASES/SALES 1Y | 0 / 54 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $174,781.11 |
| COMPANY PREVIOUS TRADES |